Deal Announcements

NeuroPhage Pharmaceuticals Nabs New Venture Capital

Wednesday, March 26, 2014 5:53:00 AM PDT | VentureDeal

   Cambridge, Massachusetts  --  NeuroPhage Pharmaceuticals has raised $17 million in its Series D round of venture capital investment.

NeuroPhage is developing a protein disaggregation platform for the treatment of neurodegenerative diseases.

Investors in the financing were not disclosed by the company in its press release.

NeuroPhage said it would use the financing to progress on an "IND-enabling for NPT088 and prepare for the clinical evaluation of a completely new approach to treat devastating neurological diseases."

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1